Search
Atara Biotherapeutics Inc
ATRAAdd to Watchlist
8.560USD
0.0000.00%
Market hours 09/23, 15:43（ET）
77.13MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
-15.33%
1 Month
-11.75%
6 Months
+76.68%
Year to Date
-52.68%
1 Year
-34.00%
Key Figures
8.920Open
8.950High
0.00Volume
LossP/E TTM
9.66P/E Dynamic
--Dividend TTM
0.01%Turnover Ratio
8.560Prev. Close
8.400Low
0.00Turnover
LossP/E Static
-2.08P/B
0.00%Div Yield TTM
-23.08%ROA
19.14552wk High
0.02Volume Ratio
-85.40MNet Profit
9.01MShares
-1.4123EPS TTM
0.08Beta
-2014.86%ROE
3.92052wk Low
13.44%Amplitude
69.68%Gross Margin
77.13MMarket Cap
-0.42Reward/Risk
9.07%Risk Rate
More news coming soon, stay tuned...
Atara Biotherapeutics Inc's Score
0.06vs previous score
Forecast7.50
Financial Health5.21
Technical4.52
Valuation Dimensions8.56
Institutional Confidence3.00
Risk Assessment2.69
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Atara Biotherapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.32/-0.32
Revenue / Forecast
630.00K/366.67K
Atara Biotherapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolATRA
Number of employees153
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Panacea Venture | 14.64% |
| Adiumentum Capital Fund I LP | 14.26% |
| EcoR1 Capital, LLC | 11.99% |
| Redmile Group, LLC | 4.90% |
| Shareholder Types | Proportion |
|---|---|
| Venture Capital | 19.18% |
| Investment Advisor/Hedge Fund | 16.32% |
| Corporation | 15.10% |
| Investment Advisor | 6.03% |
Related Instruments
+1.60%
+1.61%
+0.35%
+1.18%
+0.63%
+0.23%
+0.40%
-0.40%
+0.52%
+1.19%
+2.19%
+0.59%
+0.80%
+0.30%
-0.67%
+0.30%
+1.04%
+0.42%
-1.17%
+0.69%Popular Instruments
51403.400
-86.600 (-0.17%)
30243.700
-234.200 (-0.77%)
7674.500
-32.500 (-0.42%)
14267.000
-155.000 (-1.07%)
65623.000
-506.000 (-0.77%)
6295.400
+5.400 (+0.09%)
93.843
+1.353 (+1.46%)
336.470
-0.550 (-0.16%)
221.750
-3.760 (-1.67%)
4272.470
-13.770 (-0.32%)
FAQs
What is the current price of Atara Biotherapeutics Inc (ATRA)?
The current price of Atara Biotherapeutics Inc (ATRA) is 8.56.
What is the symbol of Atara Biotherapeutics Inc?
The ticker symbol of Atara Biotherapeutics Inc is ATRA.
What is the 52-week high of Atara Biotherapeutics Inc?
The 52-week high of Atara Biotherapeutics Inc is 19.14.
What is the 52-week low of Atara Biotherapeutics Inc?
The 52-week low of Atara Biotherapeutics Inc is 3.92.
What is the market capitalization of Atara Biotherapeutics Inc?
The market capitalization of Atara Biotherapeutics Inc is 77.13M.
Is Atara Biotherapeutics Inc (ATRA) currently rated as Buy, Hold, or Sell?
According to analysts, Atara Biotherapeutics Inc (ATRA) has an overall rating of Buy, with a price target of 13.67.
What is the Earnings Per Share (EPS TTM) of Atara Biotherapeutics Inc (ATRA)?
The Earnings Per Share (EPS TTM) of Atara Biotherapeutics Inc (ATRA) is -1.41.